Search

Search Results

• Primary multi-drug resistant tuberculosis presented as lymphadenitis in a patient without HIV infection

  S.M. Mirsaeidi, P. Tabarsi, M.O. Edrissian, M. Amiri, P. Farnia, S.D. Mansouri, M.R. Masjedi, A.A. Velayati

  2004-12-30

  https://doi.org/10.4081/monaldi.2004.690

  935

  PDF: 590

• Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis

  C. Incorvaia, C. Pravettoni, M. Mauro, M.-R. Yacoub, F. Tarantini, G.G. Riario-Sforza

  2016-01-26

  https://doi.org/10.4081/monaldi.2008.401

  1743

  PDF: 894

• Cost impact of culture reversion in extensively drug-resistant tuberculosis in Pakistan: a multi-center retrospective study

  Muhammad Abubakar, Rimsha Mukhtar, Matti Ullah, Mahnoor Irfan

  2026-02-18

  https://doi.org/10.4081/monaldi.2026.3747

  241

  PDF_EARLY VIEW: 127

  SUPPLEMENTARY MATERIAL: 22

• Demographics and microbiological profile of Pneumonia in United Arab Emirates

  S. Al-Muhairi, T. Zoubeidi, M. Ellis, M. Gary Nicholls, W. Safa, J. Joseph

  2016-02-15

  https://doi.org/10.4081/monaldi.2006.580

  1824

  PDF: 850

• Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens

  Akshata Gore, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud

  2025-08-05

  https://doi.org/10.4081/monaldi.2025.3340

  2158

  PDF_EARLY VIEW: 649

• Determinants of treatment outcome in children with multidrug-resistant tuberculosis: a tertiary care hospital experience

  Sajjad Sarwar, Muhammad Sajid, Saba Mukhtar, Rabbiya Ahmad, Sana Sarwar, Madiha Mukhtar, Muhammad Atif

  2025-05-22

  https://doi.org/10.4081/monaldi.2025.3367

  775

  PDF_EARLY VIEW: 274
• 

  Determinants, risk factors and spatial analysis of multi-drug resistant pulmonary tuberculosis in Jodhpur, India

  Nikhilesh Ladha, Pankaj Bhardwaj, Nishant Kumar Chauhan, Kikkeri Hanumantha Setty Naveen, Vijaya Lakshmi Nag, Dandabathula Giribabu

  2022-01-18

  https://doi.org/10.4081/monaldi.2022.2026

  3027

  PDF: 1881
• 

  Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19

  Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1646

  3189

  PDF: 1471

  Supplementary: 275
• 

  Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018

  Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1649

  2161

  PDF: 1023

  Supplementary: 221

• Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan

  Abdul Wahid, Nafees Ahmad, Fahad Saleem, Amjad Khan, Asad Khan, Faiz Ullah Khan, Farman Ullah Khan

  2025-04-24

  https://doi.org/10.4081/monaldi.2025.3200

  1250

  PDF_EARLY VIEW: 328
• 

  Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country

  Shayan Shahid, Kausar Jabeen, Nousheen Iqbal, Joveria Farooqi, Muhammad Irfan

  2021-04-22

  https://doi.org/10.4081/monaldi.2021.1771

  1851

  PDF: 987

• Prolonged hospitalisation for immigrants and high risk patients with positive smear pulmonary tuberculosis

  R. Luzzati, M. Confalonieri, A. Cazzadori, P. Della Loggia, R. Cifaldi, C. Fabris, M. Biolo, M. Borelli, C. Longo, E. Concia

  2015-12-10

  https://doi.org/10.4081/monaldi.2011.229

  1098

  PDF: 685

• Multidrug-resistant tuberculosis in Iran: a multicenter study

  Fatemeh Khelghati, Fatemeh Nasirpour Seilakhori, Mehdi Goudarzi, Shima Malekloo, Amir Hashem Shahidi Bonjar, Hossein Goudarzi, Mohammad Javad Nasiri

  2024-01-12

  https://doi.org/10.4081/monaldi.2024.2844

  1346

  PDF: 396

• Health-related quality of life based on the European Questionnaire 5D-5L utility score in patients with multidrug-resistant tuberculosis

  Oki Nugraha Putra, Nur Indah, Fristia Rif’atul Chumaidah, Telly Purnamasari, Muhammad Arif Saifudin

  2025-08-06

  https://doi.org/10.4081/monaldi.2025.3450

  1356

  PDF_EARLY VIEW: 335

• Bronchoscopic valve therapy for tuberculosis: a scoping review

  Kshitij Agarwal, Adam T. Gray, Tudor P. Toma, Valentina Luzzi, Lorenzo Corbetta

  2025-03-05

  https://doi.org/10.4081/monaldi.2025.3281

  935

  PDF_EARLY VIEW: 383
• 

  Comparison of efficacy of bedaquiline and moxifloxacin in drug resistant pulmonary tuberculosis. A prospective observational study

  Govind Desai, Gopal Purohit, Hemant Borana, Kunal Deokar, Suresh Yogi

  2022-05-04

  https://doi.org/10.4081/monaldi.2022.2231

  2142

  PDF: 485
• 

  Mycobacterium kansasaii and Mycobacterium scrofulaceum dual pulmonary infection in an immunocompetent male: first report from India

  Ranganath T. Ganga, Pratibha Sharma, Saroj K. Pati, Ajoy K. Behera, Sunil K. Reddy

  2022-11-02

  https://doi.org/10.4081/monaldi.2022.2371

  1287

  PDF: 351

• Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis

  Unnati Desai, Saby AK, Ketaki Utpat, Jyoti Bacche

  2024-07-25

  https://doi.org/10.4081/monaldi.2024.2909

  1304

  PDF: 210